BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 7631402)

  • 1. Anti-A and/or anti-B is not detectable in some patients who underwent ABO-incompatible bone marrow transplantation.
    Maeda K; Taniwaki K; Santo T; Itsukuma T; Ito M; Anan K; Misawa M; Ohe Y; Kai S; Hara H
    Transfusion; 1995 Aug; 35(8):635-9. PubMed ID: 7631402
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-A isoagglutinin as a risk factor for the development of pure red cell aplasia after major ABO-incompatible allogeneic bone marrow transplantation.
    Lee JH; Lee KH; Kim S; Lee JS; Kim SH; Kwon SW; Kim WK
    Bone Marrow Transplant; 2000 Jan; 25(2):179-84. PubMed ID: 10673677
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [ABO-incompatible allogeneic bone marrow transplantation].
    Xu L; Guo N; Wang S
    Zhonghua Xue Ye Xue Za Zhi; 1999 Aug; 20(8):413-5. PubMed ID: 11721421
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ABO-incompatible living-donor lobar lung transplantation.
    Shoji T; Bando T; Fujinaga T; Chen F; Yurugi K; Maekawa T; Date H
    J Heart Lung Transplant; 2011 Apr; 30(4):479-80. PubMed ID: 21168345
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transfusion-related problems following major ABO-incompatible bone marrow transplantation.
    Tasaki T; Satoh S; Gotoh K; Fujii K; Sasaki S; Takadate J; Tachibana M; Ono Y; Ishida Y
    Transfus Apher Sci; 2003 Apr; 28(2):155-61. PubMed ID: 12679120
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Production of anti-ABO blood group antibodies after minor ABO-incompatible bone marrow transplantation in NOD/SCID/gamma(c)(null) mice.
    Tomita H; Fuchimoto Y; Mori T; Kato J; Uemura T; Handa M; Tazawa H; Ohdan H; Okamoto S; Kuroda T
    Clin Transplant; 2013; 27(6):E702-8. PubMed ID: 24125194
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Severe hemolytic anemia due to multiple red cell alloantibodies after an ABO-incompatible allogeneic bone marrow transplant.
    López A; de la Rubia J; Arriaga F; Jiménez C; Sanz GF; Carpio N; Marty ML
    Transfusion; 1998 Mar; 38(3):247-51. PubMed ID: 9563404
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pure red-cell aplasia of long duration after major ABO-incompatible bone marrow transplantation.
    Volin L; Ruutu T
    Acta Haematol; 1990; 84(4):195-7. PubMed ID: 2125785
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Erythrocyte repopulation after major ABO incompatible transplantation with lymphocyte-depleted bone marrow.
    Bär BM; Van Dijk BA; Schattenberg A; de Man AJ; Kunst VA; de Witte T
    Bone Marrow Transplant; 1995 Dec; 16(6):793-9. PubMed ID: 8750272
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Immunohematologic surveillance of patients treated with ABO incompatible bone marrow allografts].
    Mizon P; Jouet JP; Vanhaesbroucke C; Villard F; Wibaut B; Goudemand J
    Transfus Clin Biol; 1994; 1(4):271-7. PubMed ID: 7921283
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Higher Anti-A/B isoagglutinin titers of IgG class, but not of IgM, are associated with increased red blood cell transfusion requirements in bone marrow transplantation with major ABO-mismatch.
    De Santis GC; Garcia-Silva AC; Dotoli GM; de Castro PT; Simões BP; Covas DT
    Clin Transplant; 2017 Apr; 31(4):. PubMed ID: 28160319
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Donor-derived red blood cell antibodies and immune hemolysis after allogeneic bone marrow transplantation.
    Hows J; Beddow K; Gordon-Smith E; Branch DR; Spruce W; Sniecinski I; Krance RA; Petz LD
    Blood; 1986 Jan; 67(1):177-81. PubMed ID: 3079641
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ABO-incompatible bone marrow transplantation: preparation by plasma exchange and in vivo antibody absorption.
    Berkman EM; Caplan S; Kim CS
    Transfusion; 1978; 18(4):504-8. PubMed ID: 356351
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transplantation of ABO-incompatible bone marrow and peripheral blood stem cell components.
    Rowley SD; Liang PS; Ulz L
    Bone Marrow Transplant; 2000 Oct; 26(7):749-57. PubMed ID: 11042656
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transmission of an anti-RhD alloantibody from donor to recipient after ABO-incompatible BMT.
    Franchini M; de Gironcoli M; Gandini G; Vassanelli A; Rocca P; Benedetti F; Aprili G
    Bone Marrow Transplant; 1998 May; 21(10):1071-3. PubMed ID: 9632284
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bone marrow transplantation for leukemia and aplastic anemia: management of ABO incompatibility.
    Curtis JE; Messner HA
    Can Med Assoc J; 1982 Mar; 126(6):649-55. PubMed ID: 7039802
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ABO-incompatible bone marrow transplantation.
    Wiesneth M; Hertenstein B; Bunjes D; Schmeiser T; Maccari B; Northoff H; Laasch H; Heit W; Arnold R; Heimpel H
    Beitr Infusionsther; 1992; 30():354-8. PubMed ID: 1284733
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiple red blood cell antibodies produced by donor B lymphocytes after ABO-matched allogeneic bone marrow transplantation.
    Tasaki T; Sasaki S; Gotoh K; Itoh C; Itoh S; Kuriya S
    Transfus Sci; 1999 Apr; 20(2):121-7. PubMed ID: 10539115
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serological complications of a major ABO incompatible bone marrow transplantation in a Polynesian with aplastic anemia.
    Ockelford PA; Hill RS; Nelson L; Blacklock HA; Woodfield DG; Matthews JR
    Transfusion; 1982; 22(1):62-5. PubMed ID: 7039010
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ABO-incompatible bone-marrow transplantation: removal of red blood cells from donor marrow avoiding recipient antibody depletion.
    Blacklock HA; Gilmore MJ; Prentice HG; Hazlehurst GR; Evans JP; Ma DD; Knight CB; Hoffbrand AV
    Lancet; 1982 Nov; 2(8307):1061-4. PubMed ID: 6127543
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.